Tag Archives: Medtronic

Three for all: What’s new in 2013

Share

Three Things To Watch in 2013

Share

Dinner at the end of the Medtronic Infuse story

I consider myself an omnivore, but I never much cared for the taste of crow. All the same, it seems there’s some bird meat on the menu thanks to a blog I posted last year about the problems Medtronic was…

Share

Once again, the FDA budget dynamic

No doubt some are tired of hearing me go on about the FDA budget, but industry thinks the agency is under-funded, too. Most who are part of this discussion believe FDA would be more functional with appropriate appropriations, but they…

Share

St. Jude in spat over Heart Rhythm paper

Share

Medtronic, the face of Med Tax opposition?

Don’t look now, but Medtronic has quite possibly just become the poster child of the opposition against the Medical Device Tax. During a call with analysts in February, the med-tech giant said that it expected to pay up to $175…

Share

Medtronic plans to enter ED market

Medtronic has the potential to be a trend setter with its attempt to have drug eluting stents (DES) treat erectile dysfunction (ED).

Share

A whole new world

Five years ago this month my byline began appearing on the pages of Medical Device Daily. When I first joined the MDD staff in October 2006 I knew very little about this industry. It was like moving to a new…

Share

A tinkerer at heart, Wilson Greatbatch epitomized what that means to medicine

A prolific inventor who died last week in upstate New York at the age of 92, Wilson Greatbatch is credited with more than 325 patents, including coming up with the first practical implantable pacemaker.

Share

Could Medtronic eventually shed Infuse?

After Johnson & Johnson (J&J, New Brunswick, New Jersey) said that it was going to discontinue its work in the drug eluting stent (DES) market, my eyes then began to focus on Medtronic (Minneapolis), which has recently taken a beating…

Share

Marketo